- 72.3k views
Hepatitis B & C: Overview
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
About the Speaker
Dr. Uday Sanglodkar
Senior Consultant - Hepatology and Liver Transplant Global Hospital, Mumbai
About the Speaker Dr. Uday Sanglodkar is currently working as Senior Consultant - Hepatology and Liver Transplant Clinical Lead Liver intensive care. Dr Uday has worked at Rela Institute and Medical centre (RIMC) as a Consultant Hepatologist and Liver Transplant physician for 3 years. Dr Uday is a Senior Consultant with vast experience in hepatology/ transplant Hepatology. His areas of interest include Hepatobiliary diseases, liver intensive care and transplant Hepatology.
Upcoming Case Discussions
Scale Healthcare Brands with AI-Powered Marketing
The AI revolution in medicine is transforming healthcare, making it smarter and more efficient than ever before. From early disease detection to personalized treatment plans, AI empowers doctors with data-driven insights for better decision-making. Robotic surgeries and AI-assisted diagnostics are enhancing precision and reducing human error. AI also improves patient care through virtual assistants and remote monitoring tools. This technological leap is paving the way for a future where healthcare is more accessible, accurate, and innovative.
Comprehensive Approaches to Pediatric Practice
Comprehensive approaches to pediatric practice emphasize holistic care that integrates early screening, preventive measures, and tailored treatments. These strategies involve using tools like the NISA card for early detection of conditions such as iron deficiency anemia. Regular anthropometric assessments provide insight into growth and development, allowing for early intervention. Incorporating neurodevelopmental screening tools ensures that cognitive, emotional, and physical milestones are monitored effectively. Collaborative care models, including parental involvement and education, support continuous patient engagement. Digital health tools can enhance monitoring and streamline consultations. Multidisciplinary teams can address complex cases more efficiently. Preventive care and health education are prioritized to reduce long-term risks. Comprehensive approaches foster a proactive environment that adapts to each child's needs. The result is improved health outcomes and overall child well-being.
Case Based Discussion on Bronchiolitis
Bronchiolitis is a common respiratory infection in infants and young children, primarily caused by the respiratory syncytial virus (RSV). It presents with nasal congestion, cough, wheezing, and difficulty breathing, often following an upper respiratory infection. Management is largely supportive, focusing on hydration, oxygen therapy, and suctioning nasal secretions. Routine use of bronchodilators, steroids, or antibiotics is not recommended. Severe cases may require hospitalization for respiratory support, such as high-flow nasal cannula or mechanical ventilation. Preventive measures include proper hand hygiene and, in high-risk infants, palivizumab prophylaxis. Prompt recognition and appropriate care are key to reducing complications and improving outcomes.
Diabetic Complications in 12 Questions
Diabetic complications in 12 Questions" is designed to address common concerns related to the long-term effects of diabetes, such as neuropathy, retinopathy, and cardiovascular issues. Through a Q&A format, the session aims to educate participants on prevention, early detection, and management strategies for these complications to improve overall diabetic care.
Management of ICU Delirium
The management of ICU delirium involves a combination of preventive strategies, such as early mobilization, minimizing sedation, and addressing underlying medical causes, to reduce the risk and severity of delirium in critically ill patients. Treatment includes optimizing the patient's environment, using non-pharmacological interventions, and, if necessary, medications to manage symptoms while focusing on long-term cognitive recovery.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Uday Sanglodkar 's Talks on Assimilate
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.